Reaktionsgleichung
[Cl:1][C:2]1[CH:18]=[CH:17][C:5]2[C:6](=O)[N:7]3[CH2:15][CH2:14][CH2:13][CH:8]3[C:9](=[O:12])[N:10]([CH3:11])[C:4]=2[CH:3]=1.CN1C2C=CC=CC=2C(=O)N2CCCC2C1=O>>[Cl:1][C:2]1[CH:18]=[CH:17][C:5]2[CH2:6][N:7]3[CH2:15][CH2:14][CH2:13][CH:8]3[C:9](=[O:12])[N:10]([CH3:11])[C:4]=2[CH:3]=1Komponenten
3
Edukt 2
Produkt 1
Versuchsvorschrift
This compound is obtained when (+)-8-chloro-1,2,3,11 a-tetrahydro-10-methyl-5 H-pyrrolo[2,1-c] [1,4] benzodiazepin-5,11(10H)-dione (melting point 191° -194°C. prepared from L-proline and 4-chloro-N-methylisatoic anhydride is described in Example 1) is substituted for (+) 1,2,3,11a-tetrahydro-10 -methyl-5 H-pyrrolo[2,1-c] [1,4] benzodiazepin-5,11(10H)-dione in the process of Example 1.
Quellen und Nachweise
- ORD-Eintrag
- ord-992412ba57cf442cb2c356e023131340
- Quelldatensatz
- uspto-grants-1976_03
- Patentnummer
- US03947408
Verknüpfte Notizen
Wird geladen…